Printed from Voxsanity (voxsanity.com.au) — NCT06727721 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Phase 2 Type 2 Diabetes Trial, Recruiting
NCT06727721
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with type 2 diabetes according to WHO standards, with a fasting blood glucose level of 7.0 mmol/L or higher, who are between 30 and 75 years old (any gender).
- People who are able to clearly understand the purpose of the trial, are willing to follow all trial requirements, and are prepared to sign a consent form.
- People whose Body Mass Index (BMI) falls between 20 and 30 kg/m².
- People whose glycated hemoglobin (a measure of long-term blood sugar control, sometimes called HbA1c) is between 7.5% and 10%.
- People who have been using insulin injections under the skin for more than six months, and whose insulin dose and/or other approved blood sugar medications (metformin only, or a specific type of enzyme-blocking medication) have remained unchanged for at least the 3 months before joining the trial.
- People who are willing to use effective contraception throughout the study period, if they are capable of having children.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with type 1 diabetes, gestational diabetes (diabetes during pregnancy), or other specific types of diabetes that are not type 2.
- People with severe allergies generally, or a known allergy to any ingredient used in cell culture processes.
- People who have taken medications that affect blood sugar levels within the past month, such as steroids (glucocorticoids), certain water tablets (thiazide diuretics), the contraceptive pill, or certain antidepressants (tricyclic antidepressants).
- People who have had a serious diabetes-related emergency (such as diabetic ketoacidosis or a dangerous high blood sugar episode) within the past 6 months.
- People who have had a serious heart or brain event — such as severe heart failure (classified as NYHA grade III or IV), a heart attack, stroke, or brain bleed — within the past 6 months.
- People with abnormal blood test results, such as low white blood cell or neutrophil counts, abnormal platelet levels, or a bleeding disorder.
- People with liver or kidney problems, as indicated by specific blood test results exceeding defined limits (confirm with trial site for exact values).
- People with other serious ongoing illnesses affecting major body systems, such as cancer, nervous system conditions, heart conditions, blood disorders, digestive conditions, hormonal disorders, breathing problems, urinary or reproductive system diseases, or immune system conditions.
- People currently being treated with systemic steroids (such as glucocorticoids), immune-suppressing medications, or cell-destroying (cytotoxic) therapies.
- People who have taken antibiotics within the 3 months before joining the trial.
- People who have received a live or weakened (attenuated) vaccine within 4 weeks before joining, or who plan to receive one during the trial.
- People who test positive for hepatitis B surface antigen (HBsAg), hepatitis C antibodies, HIV, or syphilis.
- People with an active infection requiring treatment, such as active hepatitis B, hepatitis C, or tuberculosis.
- People with a fever of unknown cause.
- People with significant disabilities (including blindness, deafness, muteness, intellectual disability, or physical disability) or a diagnosed mental illness.
- People with a history of drug or alcohol dependence or abuse within the past 5 years, or current substance use that could interfere with the trial.
- People who are pregnant, breastfeeding, planning to become pregnant, or not using effective contraception (for those who could become pregnant).
- People who have received stem cell treatment or taken part in another clinical trial within the 3 months before joining this trial.
- People who are still experiencing side effects (graded level 2 or higher) from a previous medication within 4 weeks before the trial begins.
- People with a congenital or acquired immune system disorder, or a history of organ transplantation.
- People with other serious illnesses that may affect how the treatment is delivered or how results are measured.
- People whose overall condition the trial doctors consider unsuitable for inclusion, based on their clinical judgement.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: 021-18801784133
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 2
Sponsor
Lu jin ，MD
Registry
ClinicalTrials.gov
Start date
6 November 2023
Est. completion
12 December 2028
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Daily insulin dose is used
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.